These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 26479054)

  • 1. [Genetic approach to nephrolithiasis].
    Marangella M; Marcuccio C; Vitale C
    G Ital Nefrol; 2015; 32 Suppl 64():. PubMed ID: 26479054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Inherited monogenic kidney stone diseases: recent diagnostic and therapeutic advances].
    Jungers P; Joly D; Blanchard A; Courbebaisse M; Knebelmann B; Daudon M
    Nephrol Ther; 2008 Jul; 4(4):231-55. PubMed ID: 18499551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Childhood nephrolithiasis and nephrocalcinosis caused by metabolic diseases and renal tubulopathy: A retrospective study from 2 tertiary centers.
    Kari JA; Shalaby MA; Qari FA; Albanna AS; Alhasan KA
    Saudi Med J; 2022 Jan; 43(1):81-90. PubMed ID: 35022288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The genetics of nephrolithiasis.
    Sayer JA
    Nephron Exp Nephrol; 2008; 110(2):e37-43. PubMed ID: 18758188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephrolithiasis and Nephrocalcinosis in Children - Metabolic and Genetic Factors.
    Tasic V; Gucev Z
    Pediatr Endocrinol Rev; 2015 Sep; 13(1):468-76. PubMed ID: 26540764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRPV5 in renal tubular calcium handling and its potential relevance for nephrolithiasis.
    van der Wijst J; van Goor MK; Schreuder MF; Hoenderop JG
    Kidney Int; 2019 Dec; 96(6):1283-1291. PubMed ID: 31471161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ESRD caused by nephrolithiasis: prevalence, mechanisms, and prevention.
    Jungers P; Joly D; Barbey F; Choukroun G; Daudon M
    Am J Kidney Dis; 2004 Nov; 44(5):799-805. PubMed ID: 15492945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics of kidney stone disease.
    Howles SA; Thakker RV
    Nat Rev Urol; 2020 Jul; 17(7):407-421. PubMed ID: 32533118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic testing enables a precision medicine approach for nephrolithiasis and nephrocalcinosis in pediatrics: a single-center cohort.
    Huang L; Qi C; Zhu G; Ding J; Yuan L; Sun J; He X; Wang X
    Mol Genet Genomics; 2022 Jul; 297(4):1049-1061. PubMed ID: 35612621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nephrolithiasis.
    Scheinman SJ
    Semin Nephrol; 1999 Jul; 19(4):381-8. PubMed ID: 10435676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary proteome in inherited nephrolithiasis.
    Capolongo G; Zacchia M; Perna A; Viggiano D; Capasso G
    Urolithiasis; 2019 Feb; 47(1):91-98. PubMed ID: 30564846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary hypophosphatemic rickets with hypercalciuria: case report.
    Areses-Trapote R; López-García JA; Ubetagoyena-Arrieta M; Eizaguirre A; Sáez-Villaverde R
    Nefrologia; 2012 Jul; 32(4):529-34. PubMed ID: 22806288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetics of hypercalciuric stone forming diseases.
    Devuyst O; Pirson Y
    Kidney Int; 2007 Nov; 72(9):1065-72. PubMed ID: 17687260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystalline nephropathy due to 2,8-dihydroxyadeninuria: an under-recognized cause of irreversible renal failure.
    Nasr SH; Sethi S; Cornell LD; Milliner DS; Boelkins M; Broviac J; Fidler ME
    Nephrol Dial Transplant; 2010 Jun; 25(6):1909-15. PubMed ID: 20064951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Living kidney donation from people at risk of nephrolithiasis, with a focus on the genetic forms.
    Gambaro G; Zaza G; Citterio F; Naticchia A; Ferraro PM
    Urolithiasis; 2019 Feb; 47(1):115-123. PubMed ID: 30470867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Diagnosis of Primary Hyperoxaluria Type 1 and Distal Renal Tubular Acidosis in Moroccan Patients With Nephrolithiasis and/or Nephrocalcinosis.
    Fatima A; Mohamed A; Moustapha H; Karim O
    Cureus; 2022 Mar; 14(3):e23616. PubMed ID: 35505724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ambulatory evaluation of nephrolithiasis: an update of a 1980 protocol.
    Levy FL; Adams-Huet B; Pak CY
    Am J Med; 1995 Jan; 98(1):50-9. PubMed ID: 7825619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors increasing the risk for stone formation in adult patients with cystic fibrosis.
    Terribile M; Capuano M; Cangiano G; Carnovale V; Ferrara P; Petrarulo M; Marangella M
    Nephrol Dial Transplant; 2006 Jul; 21(7):1870-5. PubMed ID: 16595587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Metabolic changes in 2612 patients with nephrolithiasis].
    del Valle E; Spivacow R; Zanchetta JR
    Medicina (B Aires); 1999; 59(5 Pt 1):417-22. PubMed ID: 10684159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.